Understanding how SARS-CoV-2 resists human immune responses
SARS-CoV-2 and Innate Immunity: Mechanisms of Resistance to Human Interferons
This study is looking at how different versions of the COVID-19 virus have changed to avoid being fought off by our body's natural defenses, which could help us develop better treatments and vaccines for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Eastern Colorado Health Care System NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10943904 on NIH RePORTER |
What this research studies
This research investigates how the SARS-CoV-2 virus, responsible for COVID-19, has evolved to resist the body's innate immune responses, particularly the effects of various human interferons. By examining different variants of the virus, the study aims to uncover the mechanisms that allow these variants to evade immune detection and response. The research employs advanced molecular techniques to analyze viral genes and their interactions with the immune system, providing insights that could inform future treatments and vaccines.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been diagnosed with COVID-19, particularly those experiencing acute symptoms or complications.
Not a fit: Patients who have not been infected with SARS-CoV-2 or those with chronic conditions unrelated to COVID-19 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for treating COVID-19 and enhancing vaccine efficacy against emerging variants.
How similar studies have performed: Previous research has shown success in understanding viral resistance mechanisms in other pathogens, suggesting that this approach could yield valuable insights for SARS-CoV-2 as well.
Where this research is happening
Aurora, UNITED STATES
- VA Eastern Colorado Health Care System — Aurora, United States (Active)
Researchers
- Principal investigator: Poeschla, Eric M. — VA Eastern Colorado Health Care System
- Study coordinator: Poeschla, Eric M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.